{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:22:23Z","timestamp":1793906543868,"version":"4.8.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["DE022550"],"award-info":[{"award-number":["DE022550"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DE022550"],"award-info":[{"award-number":["DE022550"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["DE022550"],"award-info":[{"award-number":["DE022550"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["DE022550"],"award-info":[{"award-number":["DE022550"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.coi.2021.07.011","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T06:33:32Z","timestamp":1629268412000},"page":"286-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Infections in the monogenic autoimmune syndrome APECED"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7553-0159","authenticated-orcid":false,"given":"Vasileios","family":"Oikonomou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5987-7817","authenticated-orcid":false,"given":"Timothy J","family":"Break","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8511-2041","authenticated-orcid":false,"given":"Sarah L","family":"Gaffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki M","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail S","family":"Lionakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2021.07.011_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nri3667","article-title":"Positive and negative selection of the T cell repertoire: what thymocytes see (and don\u2019t see)","volume":"14","author":"Klein","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri.2016.9","article-title":"AIRE expands: new roles in immune tolerance and beyond","volume":"16","author":"Anderson","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0015","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.011_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coi.2016.07.003","article-title":"AIRE-mutations and autoimmune disease","volume":"43","author":"Bruserud","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_sbref0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12714","article-title":"Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"287","author":"Constantine","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2021.07.011_bib0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coi.2017.10.003","article-title":"Insights into immune tolerance from AIRE deficiency","volume":"49","author":"Proekt","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0035","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","article-title":"Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0040","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2016-1821","article-title":"A longitudinal follow-up of autoimmune polyendocrine syndrome type 1","volume":"101","author":"Bruserud","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coi.2021.07.011_bib0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2021.07.011_bib0050","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1210\/jc.2017-00139","article-title":"Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1","volume":"102","author":"Orlova","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coi.2021.07.011_sbref0055","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.011_sbref0060","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s40618-020-01323-4","article-title":"A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor","volume":"43","author":"Beccuti","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.coi.2021.07.011_bib0065","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1084\/jem.20061864","article-title":"Spontaneous autoimmunity prevented by thymic expression of a single self-antigen","volume":"203","author":"DeVoss","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0070","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41467-021-21015-8","article-title":"GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility","volume":"12","author":"Eriksson","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2021.07.011_sbref0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5597","article-title":"Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance","volume":"11","author":"Ferre","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0080","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20131889","article-title":"Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance","volume":"211","author":"Khan","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/srep20104","article-title":"Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1","volume":"6","author":"Landegren","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2021.07.011_bib0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9186","article-title":"Transglutaminase 4 as a prostate autoantigen in male subfertility","volume":"7","author":"Landegren","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0095","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.immuni.2015.04.021","article-title":"Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases","volume":"42","author":"Oftedal","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.07.011_bib0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000284","article-title":"Identification of an autoantigen demonstrates a link between interstitial lung disease and a defect in central tolerance","volume":"1","author":"Shum","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0105","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1073\/pnas.1120607109","article-title":"Detection of an autoreactive T-cell population within the polyclonal repertoire that undergoes distinct autoimmune regulator (Aire)-mediated selection","volume":"109","author":"Taniguchi","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.07.011_bib0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.immunol.25.022106.141532","article-title":"Aire","volume":"27","author":"Mathis","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0115","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55053","article-title":"Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq","volume":"9","author":"Vazquez","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.coi.2021.07.011_bib0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24051-6","article-title":"Genome-wide association study identifies five risk loci for pernicious anemia","volume":"12","author":"Laisk","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2021.07.011_bib0125","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/jmg.29.11.824","article-title":"Polyglandular autoimmune syndrome type I among Iranian Jews","volume":"29","author":"Zlotogora","year":"1992","journal-title":"J Med Genet"},{"key":"10.1016\/j.coi.2021.07.011_bib0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-042617-053318","article-title":"Host control of fungal infections: lessons from basic studies and human cohorts","volume":"36","author":"Lionakis","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis","volume":"206","author":"Conti","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0140","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4049\/jimmunol.0903739","article-title":"IL-17RC is required for immune signaling via an extended SEF\/IL-17R signaling domain in the cytoplasmic tail","volume":"185","author":"Ho","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0145","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.immuni.2013.09.002","article-title":"An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis","volume":"39","author":"Boisson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.07.011_bib0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.20141065","article-title":"Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis","volume":"212","author":"Ling","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.011_bib0160","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0165","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2011.09.010","article-title":"Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E","volume":"35","author":"Chang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.07.011_bib0170","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jid.2018.01.036","article-title":"Neutralization of IL-17C reduces skin inflammation in mouse models of psoriasis and atopic dermatitis","volume":"138","author":"Vandeghinste","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2021.07.011_bib0175","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.1800696","article-title":"Cutting edge: IL-17B uses IL-17RA and IL-17RB to induce type 2 inflammation from human lymphocytes","volume":"202","author":"Ramirez-Carrozzi","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0180","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","article-title":"The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex","volume":"181","author":"Wright","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0185","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.4049\/jimmunol.181.6.4299","article-title":"Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities","volume":"181","author":"Rickel","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0190","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/IAI.01389-13","article-title":"Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis","volume":"82","author":"Ferreira","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2021.07.011_bib0195","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.71","article-title":"Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity","volume":"5","author":"Okada","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0200","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjd.15015","article-title":"Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management","volume":"177","author":"Saunte","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2021.07.011_bib0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0215","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jaci.2019.04.029","article-title":"IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis","volume":"144","author":"Krueger","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0220","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1189\/jlb.4A0915-428R","article-title":"Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis","volume":"99","author":"Whibley","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coi.2021.07.011_bib0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(19)33161-7","article-title":"Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial","volume":"395","author":"Ritchlin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2021.07.011_bib0230","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/annrheumdis-2020-216980","article-title":"Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study","volume":"79","author":"van der Heijde","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2021.07.011_bib0235","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4049\/jimmunol.2000394","article-title":"An IL-17F.S65L knock-in mouse reveals similarities and differences in IL-17F function in oral candidiasis: a new tool to understand IL-17F","volume":"205","author":"Zhou","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0240","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/eji.201747209","article-title":"IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model","volume":"48","author":"Bichele","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2021.07.011_sbref0245","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba0570","article-title":"Oral epithelial IL-22\/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis","volume":"5","author":"Aggor","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0250","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1073\/pnas.1811866115","article-title":"Interleukin-22 promotes phagolysosomal fusion to induce protection against Salmonella enterica Typhimurium in human epithelial cells","volume":"115","author":"Forbester","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.07.011_bib0255","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","article-title":"Inflammatory bowel disease and mutations affecting the interleukin-10 receptor","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clim.2019.05.007","article-title":"Candidiasis associated with very early onset inflammatory bowel disease: First IL10RB deficient case from the National Iranian Registry and review of the literature","volume":"205","author":"Yazdani","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_sbref0265","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau4594","article-title":"Regulation of host-microbe interactions at oral mucosal barriers by type 17 immunity","volume":"5","author":"Gaffen","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2021.07.011_sbref0270","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5731","article-title":"Aberrant type 1 immunity drives susceptibility to mucosal fungal infections","volume":"371","author":"Break","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.011_bib0275","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.20130877","article-title":"Oral-resident natural Th17 cells and gammadelta T cells control opportunistic Candida albicans infections","volume":"211","author":"Conti","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0280","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2007-12-127878","article-title":"Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors","volume":"112","author":"Zonios","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.011_sbref0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108664","article-title":"Characterization of autoantibodies, immunophenotype and autoimmune disease in a prospective cohort of patients with idiopathic CD4 lymphocytopenia","volume":"224","author":"Cudrici","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_sbref0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02502","article-title":"Complete multilineage CD4 expression defect associated with warts due to an inherited homozygous CD4 gene mutation","volume":"10","author":"Fernandes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.07.011_sbref0295","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/infdis\/jiab025","article-title":"Lost in translation: lack of CD4 expression due to a novel genetic defect","volume":"223","author":"Lisco","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2021.07.011_bib0300","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1182\/blood-2010-05-283549","article-title":"Mechanisms underlying gammadelta T-cell subset perturbations in SIV-infected Asian rhesus macaques","volume":"116","author":"Harris","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.07.011_bib0305","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/mi.2012.38","article-title":"Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection","volume":"5","author":"Klatt","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0310","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05528-3","article-title":"Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells","volume":"9","author":"Mudd","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2021.07.011_bib0315","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0320","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0325","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/eji.200939883","article-title":"Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model","volume":"41","author":"Ahlgren","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0330","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaci.2010.08.027","article-title":"Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"126","author":"Ng","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0335","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10875-014-9987-5","article-title":"Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients","volume":"34","author":"Sarkadi","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0340","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3389\/fimmu.2020.00838","article-title":"IL-22 paucity in APECED is associated with mucosal and microbial alterations in oral cavity","volume":"11","author":"Kaleviste","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0345","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1172\/JCI121486","article-title":"TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome","volume":"128","author":"Myles","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.07.011_bib0350","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.07.011_bib0355","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20050693","article-title":"Modifier loci condition autoimmunity provoked by Aire deficiency","volume":"202","author":"Jiang","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0360","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.0802124","article-title":"Aire-deficient C57BL\/6 mice mimicking the common human 13-base pair deletion mutation present with only a mild autoimmune phenotype","volume":"182","author":"Hubert","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.07.011_sbref0365","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa140","article-title":"Patients with APECED have increased early mortality due to endocrine causes, malignancies and infections","volume":"105","author":"Borchers","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coi.2021.07.011_bib0370","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cen.12087","article-title":"What is the burden of living with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) in 2012? A health-related quality-of-life assessment in Finnish patients","volume":"79","author":"Kluger","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.coi.2021.07.011_bib0375","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/08916934.2017.1344972","article-title":"Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I","volume":"50","author":"Oftedal","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.coi.2021.07.011_bib0380","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3109\/08916934.2014.929666","article-title":"In vivo analysis of helper T cell responses in patients with autoimmune polyendocrinopathy - candidiasis - ectodermal dystrophy provides evidence in support of an IL-22 defect","volume":"47","author":"Laakso","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.coi.2021.07.011_bib0385","article-title":"Response to comments on \u201cAberrant type 1 immunity drives susceptibility to mucosal fungal infections\u201d","author":"Break","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.011_bib0390","doi-asserted-by":"crossref","DOI":"10.1126\/science.abi6235","article-title":"Comment on \u201cAberrant type 1 immunity drives susceptibility to mucosal fungal infections\u201d","author":"Kisand","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.011_bib0395","doi-asserted-by":"crossref","DOI":"10.1126\/science.abi5459","article-title":"Comment on \u201cAberrant type 1 immunity drives susceptibility to mucosal fungal infections\u201d","author":"Puel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.011_bib0400","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.4049\/jimmunol.1401068","article-title":"Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors","volume":"193","author":"Wolff","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0405","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0410","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0415","doi-asserted-by":"crossref","first-page":"24231","DOI":"10.1073\/pnas.1908129116","article-title":"Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity","volume":"116","author":"Araya","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.07.011_sbref0420","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10875-020-00803-9","article-title":"Three copies of four interferon receptor genes underlie a mild type I interferonopathy in down syndrome","volume":"40","author":"Kong","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0430","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1172\/JCI80477","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"125","author":"Walter","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.07.011_bib0435","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coi.2021.07.011_bib0440","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139980","article-title":"Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency","volume":"131","author":"Bastard","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.07.011_bib0445","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.20182295","article-title":"Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines","volume":"216","author":"Hernandez","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0450","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2796.2007.01786.x","article-title":"Recurrent herpes simplex virus infection in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy associated with L29P and IVS9-1G&C compound heterozygous autoimmune regulator gene mutations","volume":"261","author":"Nagafuchi","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.coi.2021.07.011_sbref0455","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0460","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00134-021-06392-4","article-title":"Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients","volume":"47","author":"Koning","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0465","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s10875-021-01036-0","article-title":"Neutralizing autoantibodies to type I IFNs in >10% of patients with severe COVID-19 pneumonia hospitalized in Madrid, Spain","volume":"41","author":"Troya","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0470","article-title":"Longitudinal single-cell epitope and RNA-seq reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19","author":"van der Wijst","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0475","doi-asserted-by":"crossref","DOI":"10.1111\/imcb.12495","article-title":"Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19","author":"Abers","year":"2021","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.coi.2021.07.011_sbref0480","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.coi.2021.07.011_sbref0485","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.07.011_sbref0490","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210554","article-title":"Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.07.011_sbref0495","doi-asserted-by":"crossref","first-page":"e150867","DOI":"10.1172\/JCI150867","article-title":"Mild COVID-19 despite autoantibodies to type I IFNs in Autoimmune-Polyendocrine-Syndrome Type 1 (APS-1)","volume":"131","author":"Meisel","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coi.2021.07.011_bib0500","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2102685","article-title":"Bamlanivimab plus etesevimab in mild or moderate covid-19","author":"Dougan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.07.011_bib0505","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaci.2021.03.034","article-title":"Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis","volume":"148","author":"Lemarquis","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.07.011_bib0510","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1073\/pnas.0809986106","article-title":"Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen","volume":"106","author":"Alimohammadi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.07.011_sbref0515","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1182\/blood.2019003900","article-title":"Fulminant pneumococcal sepsis due to APECED-associated autoimmune asplenia","volume":"135","author":"Schmitt","year":"2020","journal-title":"Blood"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521001047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521001047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:50:37Z","timestamp":1760604637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791521001047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":103,"alternative-id":["S0952791521001047"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2021.07.011","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections in the monogenic autoimmune syndrome APECED","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2021.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}